Squamous Cell Carcinoma of the Tongue in a Child with Fanconi Anemia: A Case Report and Review of the Literature

References

• Fanconi G. Familiare infantile perniziosaartige anamie (pernisioses blutbild und konstitution). Jahr Kinderheilkd 1927; 117: 257–80
   Google Scholar
• Uehlinger F. Konstitutionelle infantile (pernisiosaartige) anamie. Klin Wochenschr 1929; 8: 1501–3
   Google Scholar
• Shahidi N T. Fanconi anemia: Overview. In: Workshop on Molecular, Cellular, and Clinical Aspects of Fanconi Anemia. Exp Haematol 1993; 21: 703–26
   Google Scholar
• Strathdee C A, Gavish H, Shannon W R, Buchwald M. Cloning of cDNAs for Fanconi's anemia by functional complementation. Nature 1992; 356: 763–7
   PubMed Web of Science ®Google Scholar
• Gavish H, dos Santos C C, Buchwald M. A Leu554-to-Pro substitution completely abolishes the functional complementing activity of the Fanconi anemia protein. Hum Mol Genet 1993; 2: 123–6
   Google Scholar
• Garriga S, Crosby W. The incidence of leukemia in families of patients with hypoplasia of the marrow. Blood 1959; 14: 1008–13
   PubMed Web of Science ®Google Scholar
• Swift M R, Hirschhorn K. Fanconi's anemia: Inherent susceptibility to chromosome breakage in various tissues. Ann Intern Med 1966; 65: 496–503
   PubMed Web of Science ®Google Scholar
• Dosik H, Hsu L Y, Todaro G J, et al. Leukemia and Fanconi's anemia: Cytogenetic tumor virus susceptibility studies. Blood 1970; 36: 341–52
   Google Scholar
• Meisner L F, Taher A, Shahidi L F. Chromosomal changes and leukemic transformation in Fanconi's anemia. Aplastic Anemia, S Hibino, F Takaku, N T Shahidi. University Park Press, Baltimore 1978; 253–70
   Google Scholar
• Auerbach A D, Allen R G. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet 1991; 51: 1–12
   PubMed Web of Science ®Google Scholar
• Gutman A B. Clinicopathologic conference on Fanconi's anemia and hepatic cirrhosis. Am J Med 1965; 39: 464–75
   Google Scholar
• Guy J T, Auslander M O. Androgenic steroids and hepatocellular carcinoma. Lancet 1973; 1: 148
   PubMed Web of Science ®Google Scholar
• Swift M, Zimmerman D, McDonough E R. Squamous cell carcinomas in Fanconi's anemia. JAMA 1971; 216: 325–6
   Google Scholar
• Esparza A, Thompson W. Familial hypoplastic anemia with multiple congenital anomalies (Fanconi's syndrome): Report of three cases. RI Med J 1966; 49: 103–10
   PubMedGoogle Scholar
• Sarna G, Tomasula P, Lotz M, Bubinak J, Shulman N. Multiple neoplasms in the siblings with a variant form of Fanconi's anemia. Cancer 1975; 36: 1029–33
   Google Scholar
• Vaitiekaitis A S, Grau W H. Squamous cell carcinoma of the mandible in Fanconi anemia: Report of case. J Oral Surg 1980; 38: 372–3
   Google Scholar
• Schofield ID F, Worth A T. Malignant mucosal change in Fanconi's anemia. J Oral Surg 1980; 38: 619–22
   Google Scholar
• Reed K, Ravikumar T S, Gifford RR M, Grage T B. The association of Fanconi's anemia and squamous cell carcinoma. Cancer 1983; 52: 926–8
   PubMed Web of Science ®Google Scholar
• Kaplan M J, Sabio H, Wanebo H J, Cantrell R W. Squamous cell carcinoma in the immunosuppressed patient: Fanconi's anemia. Laryngoscope 1985; 95: 771–5
   PubMed Web of Science ®Google Scholar
• Murayama S, Manzo R P, Kirkpatrick D V, Robinson A E. Squamous cell carcinoma of the tongue associated with Fanconi's anemia: MR characteristics. Pediatr Radiol 1990; 20: 347
   Google Scholar
• Snow D G, Campbell J B, Smallman LA. Fanconi's anemia and post-cricoid carcinoma. J Laryngol Otol 1991; 105: 125–7
   Google Scholar
• Sasaki M S, Tonomura A. A high susceptibility of Fanconi's anemia to chromosomal breakage by DNA cross-linking agents. Cancer Res 1973; 33: 1829–36
   PubMed Web of Science ®Google Scholar
• Todaro G J, Green H, Swift M R. Susceptibility of human diploid fibroblast strains to transformation by SV40 virus. Science 1966; 153: 1252–4
   PubMed Web of Science ®Google Scholar
• Trizna Z, Schantz S P. Hereditary and environmental factors associated with risk and progression of head and neck cancer. Otolaryngol Clin North Am 1992; 25: 1089–103
   Google Scholar
• Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anemia: Application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54: 431–40
   PubMed Web of Science ®Google Scholar
• Dennerstein G, Scurry J, Garland S, et al. Human papillomavirus vulvitis: A new disease or an unfortunate mistake?. Brit J Obstet Gynaecol 1994; 101: 992–8
   PubMedGoogle Scholar
• Manos M M, Ting Y, Wright D K, Lewis A J, Broker T R, Wolinsky S M. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989; 7: 209–14
   Google Scholar
• Resnick R M, Cornelissen M T, Wright D K, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990; 82: 1477–82
   PubMed Web of Science ®Google Scholar
• Gregoire L, Arella M, Campione-Piccardo J, Lancaster W D. Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol 1989; 27: 2660–5
   PubMed Web of Science ®Google Scholar
• Levine A S. Workshop on Molecular, Cellular, and Clinical Aspects of Fanconi Anemia. Exp Haematol 1993; 21: 703–26
   Google Scholar
• Alter B P. Fanconi's anemia: Current concepts. Am J Pediatr Hematol Oncol 1992; 14: 170–6
   PubMedGoogle Scholar
• Strathdee C A, Buchwald M. Molecular and cellular biology of Fanconi anemia. Am J Pediatr Hematol Oncol 1992; 14: 177–85
   PubMedGoogle Scholar
• Papadopoulo D, Guillouf C, Mohnrenweiser E, Moustacchi E. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc Natl Acad Sci USA 1990; 87: 8383–7
   PubMed Web of Science ®Google Scholar
• Guillouf C, Laquerbe A, Moustacchi E, Papadopoulo D. Mutagenic processing of psoralen mono-adducts differ in normal and Fanconi anemia cells. Mutagenesis 1993; 8: 355–61
   PubMed Web of Science ®Google Scholar
• Strathdee C A, Duncan AM V, Buchwald M. Evidence for at least four Fanconi anemia genes including FACC on chromosome 9. Nat Genet 1992; 1: 196–8
   PubMed Web of Science ®Google Scholar
• Hang B, Yeung A T, Lambert M W. A damage-recognition protein which binds to DNA containing interstrand cross-links is absent or defective in Fanconi anemia, complementation group A, cells. Nucleic Acids Res 1993; 21: 4187–92
   Google Scholar
• Nordensen I. Effect of superoxide dismutase and catalase on spontaneously occurring chromosome breaks in patients with Fanconi's anemia. Hereditas 1977; 86: 147–50
   Google Scholar
• Takeuchi T, Morimoto K. Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency. Carcinogenesis 1993; 14: 1115–20
   PubMedGoogle Scholar
• Joenje H, Frants R R, Arwert F, et al. Erythrocyte superoxide dismutase deficiency in Fanconi's anemia established by two independent methods of assay. Scand J Clin Lab Invest 1979; 39: 759–64
   PubMed Web of Science ®Google Scholar
• Mavelli I, Ciriolo M R, Rotilio G, De-Sole P, Castorino M, Stabile A. Superoxide dismutase glutathione peroxidase and catalase in oxidative hemolysis. A study of Fanconi's anemia erythrocytes. Biochem Biophys Res Commun 1982; 106: 286–90
   PubMed Web of Science ®Google Scholar
• Joenje H, Arwert F, Eriksson A W, De Koning J, Oostra A B. Oxygen-dependence of chromosomal aberrations in Fanconi's anemia. Nature 1981; 290: 142–3
   PubMed Web of Science ®Google Scholar
• Schindler D, Hoehne H. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet 1988; 43: 429–35
   PubMed Web of Science ®Google Scholar
• Penn I. Cancers following cyclosporine therapy. Transplantation 1987; 43: 32–5
   PubMed Web of Science ®Google Scholar
• Pedersen F K, Hertz H, Lundsteen C, et al. Indication of primary immune deficiency in Fanconi's anemia. Acta Paediatr Scand 1977; 66: 745–51
   Google Scholar
• Johansson E, Niemi K, Siimes M, et al. Fanconi's anemia: Tumor-like warts, hyperpigmentation associated with deranged keratinocytes, and depressed cell-mediated immunity. Arch Dermatol 1982; 118: 249–52
   Google Scholar
• Hersey P, Edwards A, Lewis R, et al. Deficient natural killer cell activity in a patient with Fanconi's anemia and squamous cell carcinoma. Association with defect in interferon release. Clin Exp Immunol 1982; 48: 205–12
   Google Scholar
• Sondel P M. Tumor immunology and pediatric cancer. Principles and Practice of Pediatric Oncology, 2nd ed., P A Pizzo, D G Poplack. J. B. Lippincott, Philadelphia 1993; 81–102
   Google Scholar
• Penn I. Tumor incidence in human allograft recipients. Transplant Proc 1979; 11: 1047–52
   PubMed Web of Science ®Google Scholar
• Penn I. The development of new tumours after transplantation. Organ Transplantation and Replacement, G J Cerilli. J. B. Lippincott, Philadelphia 1988; 439–44
   Google Scholar
• Fajardo L F. Ionising radiation and neoplasia. New Concepts in Neoplasia as Applied to Diagnostic Pathology, C M Fenoglio-Prieser, et al. Williams & Wilkins, Baltimore 1986; 97
   Google Scholar
• Higurashi M, Conen P E. In vitro chromosomal sensitivity in Fanconi's anemia. Blood 1971; 38: 336–42
   Google Scholar
• Lishner M, Patterson B, Kandel R, et al. Cutaneous and mucosal neoplasms in bone marrow transplant recipients. Cancer 1990; 65: 473–6
   PubMed Web of Science ®Google Scholar
• Deeg H J, Sanders J, Martin P, et al. Secondary malignancies after marrow transplantation. Exp Hematol 1984; 12: 660–6
   PubMed Web of Science ®Google Scholar
• Socie G, Henry-Amar M, Cosset J M, Devergie A, Girinsky T, Gluckman E. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991; 78: 277–9
   PubMed Web of Science ®Google Scholar
• Korkina L G, Samochatova E V, Maschan A A, Suslova T B, Cheremisina Z P, Afanas'ev I B. Release of active oxygen radicals by leucocytes of Fanconi anemia patients. J Leukoc Biol 1992; 52: 357–62
   PubMedGoogle Scholar
• ZurHausen H, Schneider A. The papillomaviruses. The Papovaviridae, P M Howley, N P Salzman. Plenum, New York 1987; Vol. 2: 245–63
   Google Scholar
• Howley P M. Papillomavirinae and their replication. Field Virology, B N Fields, D M Knipe, R M Chanock. Raven Press, New York 1990; 1625–50
   Google Scholar
• Dyson N, Howley P M, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934–7
   PubMed Web of Science ®Google Scholar
• Werness B A, Levine A J, Howley P M. Association of human papilloma virus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76–9
   PubMed Web of Science ®Google Scholar
• Vaux D L, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Minireview. Cell 1994; 76: 1–3
   Google Scholar
• DeCaprio J A, Ludlow J W, Figge J, et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275–83
   PubMed Web of Science ®Google Scholar
• Frisque R J. Nucleotide sequence of the region encompassing the JC virus origin of DNA reduplication. J Virol 1983; 46: 170–6
   PubMedGoogle Scholar